Skip to content

"Incidence and Characteristics of Hypocalcemia after initiation or switching of calcimimetics"

"Incidence and Characteristics of Hypocalcemia after initiation or switching of calcimimetics" - "Incidence and Characteristics of Hypocalcemia after initiation or switching of calcimimetics"

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000058721
Enrollment
8800
Registered
2025-08-08
Start date
2018-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese Dialysis Patients with CKD-MBD

Interventions

None listed

Sponsors

Patient Driven Academic League
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Hemodialysis patients attending a dialysis facility as outpatients who agree to participate in the study

Exclusion criteria

Exclusion criteria: Patients on peritoneal dialysis

Design outcomes

Primary

MeasureTime frame
Primary outcome is the occurrence of hypocalcemia

Countries

Japan

Contacts

Public ContactKoji Kabaya

Patient Driven Academic League Administrative Division

admin@pedal.or.jp075-777-1261

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026